Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.58 USD | -3.43% | -5.34% | -3.06% |
14/06 | Raymond James Adjusts Price Target on Xencor to $40 From $58, Maintains Strong Buy Rating | MT |
14/06 | BMO Capital Adjusts Xencor's Price Target to $32 From $34, Keeps Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.06% | 126.9Cr | |
+18.15% | 12TCr | |
+18.02% | 11TCr | |
+5.07% | 2.29TCr | |
-12.75% | 2.22TCr | |
-9.86% | 1.7TCr | |
-14.97% | 1.69TCr | |
-39.94% | 1.69TCr | |
+2.80% | 1.36TCr | |
+27.39% | 1.16TCr |
- Stock Market
- Equities
- XNCR Stock
- News Xencor, Inc.
- Transcript : Xencor, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 01